Camrelizumab
A pharmaceutical drug for inhibiting the PD1- monoclonal antibody. It is used to treat hepatocellular carcinoma and Hodgkin lymphoma.
Currently, there are no issues on this topic.
Find more entities like Camrelizumab
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.